https://www.pappas-capital.com/fda-approves-plexxikon-drug-2/
FDA Approves Plexxikon Drug - Pappas Capital
Oct 18, 2011 - Zelboraf, the most-recent Pappas Ventures-backed product to be approved by the FDA, has attracted worldwide media interest. Click here to see the ABC News...
fdaapprovesplexxikondrugpappas
https://www.pappas-capital.com/plexxikon-daiichi-sankyo-complete-potential-935m-deal-2/
Plexxikon, Daiichi Sankyo complete potential $935M deal - Pappas Capital
Apr 4, 2011 - Daiichi Sankyo Co. Ltd. completed its acquisition of Plexxikon Inc. , giving shareholders $805 million upfront with the possibility of near-term milestone...
daiichi sankyoplexxikoncompletepotentialdeal